Startups
2021
MIMARK DIAGNOSTICS SLDiscovering new biomarkers for Women’s Health
We are specialized in the discovery, verification and validation of biomarkers to develop new solutions for gynecological patients.
We are specialized in the discovery, verification and validation of biomarkers to develop new solutions for gynecological patients.
Address
Carrer de Baldiri Reixac 15, 08028 Barcelona, Spain
Finance Data
CERCA ownership
Barcelona, Spain
2002
Vall d’Hebron Institut de Recerca (VHIR)
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
At MiMARK we care for women’s health. We are developing innovative in vitro diagnostic solutions to improve the management of gynecological malignancies. We envision the gynecological fluid as the next step in liquid biopsy in gynecology. Our first objective is to improve Endometrial Cancer diagnosis.
Product description
WomEC is an in vitro diagnostic tool based on the determination of 5 protein biomarkers in uterine fluid samples to provide diagnosis to 100% of patients, rule out endometrial cancer with great specificity, and provide information on histological subtype of the tumor to guide surgical treatment.
WomEC is now being developed as an easy, quick and less costly diagnostic kit to facilitate the clinical implementation in clinical laboratories.
WomEC is now being developed as an easy, quick and less costly diagnostic kit to facilitate the clinical implementation in clinical laboratories.